Acceleron is developing first-in-class therapies intended to transform patients’ lives.  We focus on products with unique properties that can provide meaningful advantages over existing treatments, or that can address diseases for which no approved therapies exist.  We have built a rich pipeline of biologic therapies and have four internally developed programs in clinical trials.

Revised Pipeline

  Celgene     Celgene